Halozyme Therapeutics (HALO)
(Real Time Quote from BATS)
$56.25 USD
+1.10 (2.00%)
Updated Jul 25, 2024 11:12 AM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/6/24 |
---|---|
Current Quarter | 0.78 |
EPS Last Quarter | 0.79 |
Last EPS Surprise | 14.49% |
ABR | 1.60 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.90 |
Next Year | 4.81 |
EPS (TTM) | 3.10 |
P/E (F1) | 14.13 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 210.92M | 270.24M | 988.88M | 1.16B |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 226.81M | 284.23M | 1.03B | 1.21B |
Low Estimate | 198.72M | 246.31M | 948.17M | 1.13B |
Year ago Sales | 221.04M | 216.03M | 829.25M | 988.88M |
Year over Year Growth Est. | -4.58% | 25.09% | 19.25% | 16.84% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.78 | 1.05 | 3.90 | 4.81 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | 0.73 | 0.95 | 3.65 | 4.45 |
High Estimate | 0.87 | 1.14 | 4.25 | 5.41 |
Low Estimate | 0.73 | 0.95 | 3.65 | 4.38 |
Year ago EPS | 0.74 | 0.75 | 2.77 | 3.90 |
Year over Year Growth Est. | 5.41% | 40.00% | 40.79% | 23.18% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.78 | 1.05 | 3.90 | 4.81 |
7 Days Ago | 0.78 | 1.05 | 3.90 | 4.81 |
30 Days Ago | 0.78 | 1.05 | 3.90 | 4.81 |
60 Days Ago | 0.74 | 1.00 | 3.69 | 4.50 |
90 Days Ago | 0.73 | 0.99 | 3.66 | 4.50 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.78 | 1.05 | 3.90 | 4.81 |
Zacks Consensus Estimate | 0.78 | 1.05 | 3.90 | 4.81 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.79 | 0.82 | 0.75 | 0.74 | NA |
Estimate | 0.69 | 0.82 | 0.71 | 0.63 | NA |
Difference | 0.10 | 0.00 | 0.04 | 0.11 | 0.06 |
Surprise | 14.49% | 0.00% | 5.63% | 17.46% | 9.40% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more